Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
6.05
+1.14 (23.37%)
At close: Jun 27, 2025, 4:00 PM
6.19
+0.15 (2.40%)
After-hours: Jun 27, 2025, 7:57 PM EDT
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $8.40 million as of June 27, 2025. Its market cap has increased by 63.37% in one year.
Market Cap
8.40M
Enterprise Value
-6.43M
1-Year Change
63.37%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has increased from $5.28M to $8.40M, an increase of 59.06%. That is a compound annual growth rate of 10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 6.81M | 44.77% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 215.99B |